Cooperation Agreement with Emmanuelle Charpentier's Laboratory
Posted on February 01, 2017
Today we signed a cooperation agreement with Prof. Dr. Emmanuelle Charpentier.
We are looking forward to this great partnership.
Prof. Dr. Emmanuelle Charpentier is best known for her role in deciphering the molecular mechanisms of the bacterial CRISPR-Cas9 immune system and repurposing it into a tool for genome editing. In particular she uncovered the mechanism beyond the maturation of non-coding RNA key for the CRISPR-Cas9 function. In collaboration with Jennifer Doudna's laboratory, Charpentier's laboratory showed that Cas9 could be used to make cuts in any DNA sequence desired. The method they developed involved the combination of Cas9 with easily created synthetic "guide RNA" molecules. Researchers worldwide have employed this method successfully to edit the DNA sequences of plants, animals, and laboratory cell lines.
Sources: Picture and text from wikipedia.org; Video from youtube.com (DFG channel)